Data Science Funding Announcements & Notices
Data science and informatics funding announcements and notices are available from NCI and NIH programs. Browse below for opportunities, requests for information, notices, and initiatives.
Title Sort descending | FOA | Organization | Release Date | Expire Date | Purpose |
---|---|---|---|---|---|
Substance Use/Substance Use Disorder Dissertation Research Award (R36 Clinical Trials Not Allowed) | PAR-23-194 | NIDA | The goal of this FOA is to support doctoral candidates from a variety of academic disciplines for up to two years for the completion of the doctoral dissertation research project. Research projects… More | ||
Support for Research Excellence First Independent Research (SuRE-First) Award (R16 - Clinical Trial Not Allowed) | PAR-24-145 | NIGMS | The SuRE program supports research capacity building at eligible higher education institutions through funding investigator-initiated biomedical research inbasic, social, clinical, behavioral, or… More | ||
Support for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed) | PAR-24-144 | NIGMS | The SuRE program supports research capacity building at eligible higher education institutions bythrough funding investigator-initiated biomedical research inbasic, social, clinical, behavioral, or… More | ||
Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) | RFA-CA-24-019 | NCI | The purpose of this Funding Opportunity Announcement (FOA) is to invite Cooperative Agreement (U24) applications for the continued development and sustainment of high-value informatics research… More | ||
Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE) (R01 Clinical Trial Not Allowed) | PAR-22-139 | NCI | The purpose of this Funding Opportunity Announcement (FOA) is to solicit R01 research projects utilizing state-of-the-art cancer biology methods and model systems to study effects of different types… More | ||
Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE) (R21 Clinical Trial Not Allowed) | PAR-22-140 | NCI | The STRIPE program seeks to support pre-clinical research projects utilizing state-of-the-art cancer biology methods and model systems that study how radiopharmaceutical therapy (RPT) agents affect… More | ||
Tailoring HIV Curative Strategies to the Participant (UM1 Clinical Trial Not Allowed) | RFA-AI-24-011 | NIAID | The purpose of this Notice of Funding Opportunity (NOFO) is to support the development of clinical research platforms that will enable future clinical trials to determine whether combinations of HIV… More | ||
Targeting Inflammasomes in HIV and Substance Use (R01 Clinical Trial Not Allowed) | RFA-DA-25-012 | NIDA | The scientific objective of this Notice of Funding Opportunity is to encourage research to delineate the role of inflammasomes in the neuropathology produced by acute or chronic drug exposure and HIV… More | ||
Targeting Inflammasomes in HIV and Substance Use (R21 Clinical Trial Not Allowed) | RFA-DA-25-013 | NIDA | The scientific objective of this Funding Opportunity Announcement is to encourage research to delineate the role of inflammasomes in the neuropathology produced by acute or chronic drug exposure and… More | ||
Team-Based Design in Biomedical Engineering Education (R25 Clinical Trial Not Allowed) | PAR-22-000 | NIBIB | The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this NIBIB R25 program is to support educational activities… More |